Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Polycarbophil is a synthetic, high molecular weight cross-linked polyacrylic acid polymer used as a mucoadhesive excipient. In vaginal formulations, it acts as a buffer system, slowly releasing protons (H\u005E+^ ions) via its carboxylic acid groups to maintain or restore physiological acidity and promote healthy microbial balance. Polycarbophil does not act as a receptor, enzyme, channel, or transporter; rather, it modifies the local physicochemical environment via its chemical structure and water-binding properties. In GI applications, it functions as a bulk-forming laxative by increasing stool water content and volume
Local acid-buffering (release of H\u005E+^ ions from carboxyl groups in polycarbophil to acidify environment)\nMucoadhesion increases residence time at site of application\nIn GI: bulk formation and water retention facilitate passage of stool
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Polycarbophil buffer system.